Publications by authors named "T L Castro"

The intestinal immune system must concomitantly tolerate food and commensals and protect against pathogens. Antigen-presenting cells (APCs) orchestrate these immune responses by presenting luminal antigens to CD4 T cells and inducing their differentiation into regulatory (pTreg) or inflammatory (Th) subsets. We used a proximity labeling method (LIPSTIC) to identify APCs that presented dietary antigens under tolerizing and inflammatory conditions and understand cellular mechanisms by which tolerance to food is induced and can be disrupted by infection.

View Article and Find Full Text PDF
Article Synopsis
  • Fresh, minimally processed foods are rich in beneficial phenolic compounds, while industrially processed foods tend to have lower concentrations of these nutrients.
  • The study analyzed menus from 319 schools in Sergipe, Brazil, using linear regression and cluster analysis to assess caloric content, nutrients, and polyphenols based on food processing levels.
  • Results showed that incorporating regional foods improved flavonoid and phenolic acid levels, while ultra-processed foods negatively impacted flavonoid content, highlighting the importance of food selection for school nutrition and public health.
View Article and Find Full Text PDF
Article Synopsis
  • Immunotherapy combinations are the standard treatment for advanced hepatocellular carcinoma (HCC), with growing evidence supporting lenvatinib as a strong first-line option.
  • A retrospective study analyzed 412 patients treated with either atezolizumab/bevacizumab (AZ/BV) or lenvatinib (LEN) across 18 European hospitals, revealing that those on AZ/BV experienced longer progression-free survival.
  • Despite comparable survival rates between the two treatments overall, AZ/BV posed a higher risk of liver issues in patients with pre-existing liver function impairment, highlighting the need for careful patient monitoring.
View Article and Find Full Text PDF

Dendritic cells (DCs) are uniquely capable of transporting tumor antigens to tumor-draining lymph nodes (tdLNs) and interact with effector T cells in the tumor microenvironment (TME) itself, mediating both natural antitumor immunity and the response to checkpoint blockade immunotherapy. Using LIPSTIC (Labeling Immune Partnerships by SorTagging Intercellular Contacts)-based single-cell transcriptomics, we identified individual DCs capable of presenting antigen to CD4 T cells in both the tdLN and TME. Our findings revealed that DCs with similar hyperactivated transcriptional phenotypes interact with helper T cells both in tumors and in the tdLN and that checkpoint blockade drugs enhance these interactions.

View Article and Find Full Text PDF